AbbVie Inc (ABBV)

Operating return on assets (Operating ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands 9,137,000 13,822,000 12,272,000 12,787,000 12,757,000 15,064,000 17,386,000 16,168,000 18,117,000 17,689,000 17,392,000 18,538,000 17,924,000 16,603,000 15,552,000 11,863,000 11,363,000 11,566,000 10,928,000 13,576,000
Total assets US$ in thousands 135,161,000 143,422,000 141,937,000 148,874,000 134,711,000 136,221,000 135,367,000 134,544,000 138,805,000 141,325,000 143,186,000 143,211,000 146,529,000 148,858,000 147,972,000 150,501,000 150,565,000 149,621,000 149,530,000 91,199,000
Operating ROA 6.76% 9.64% 8.65% 8.59% 9.47% 11.06% 12.84% 12.02% 13.05% 12.52% 12.15% 12.94% 12.23% 11.15% 10.51% 7.88% 7.55% 7.73% 7.31% 14.89%

December 31, 2024 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $9,137,000K ÷ $135,161,000K
= 6.76%

Operating return on assets (Operating ROA) is a key financial ratio that measures a company's efficiency in generating operating profits from its assets. For AbbVie Inc, the operating ROA fluctuated over the period analyzed.

From March 31, 2020, to September 30, 2021, the operating ROA showed a general increasing trend, indicating improving efficiency in generating operating profits from the company's assets. The ratio ranged from 14.89% on March 31, 2020, to 11.15% on September 30, 2021, demonstrating relatively strong performance during this period.

However, from December 31, 2021, to December 31, 2024, the operating ROA exhibited more volatility, with fluctuations in the range of 6.76% to 13.05%. This variability suggests some challenges or changes in the company's operations impacting its ability to generate profits from its assets consistently.

The highest operating ROA was recorded at 13.05% on December 31, 2022, while the lowest was observed at 6.76% on December 31, 2024. This indicates a wide performance range for AbbVie Inc in terms of efficiency in utilizing its assets to generate operating profits.

Overall, AbbVie Inc's operating ROA trended upwards initially, showing signs of improved efficiency, but experienced fluctuations in later periods. Further analysis would be needed to understand the factors driving these changes and their implications for the company's operational performance and asset utilization efficiency.